Lyra Therapeutics (LYRA) Non-cash Items (2019 - 2025)
Quarterly Non-cash Items changed N/A to $52210.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52210.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $52210.0 for FY2025, 98.15% down from the prior year.
Lyra Therapeutics' Non-cash Items history spans 7 years, with the latest figure at $52210.0 for Q4 2025.
- Non-cash Items came in at $52210.0 for Q4 2025, down from $1.3 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $12.9 million in Q1 2024 to a low of $52210.0 in Q4 2025.
- The 5-year median for Non-cash Items is $1.1 million (2022), against an average of $2.3 million.
- Year-over-year, Non-cash Items plummeted 94.09% in 2023 and then surged 22480.7% in 2024.
- Lyra Therapeutics' Non-cash Items stood at $918000.0 in 2021, then plummeted by 58.82% to $378000.0 in 2022, then skyrocketed by 1575.66% to $6.3 million in 2023, then tumbled by 79.48% to $1.3 million in 2024, then crashed by 95.98% to $52210.0 in 2025.
- Per Business Quant, the three most recent readings for LYRA's Non-cash Items are $52210.0 (Q4 2025), $1.3 million (Q3 2024), and $1.4 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Lyra Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 52,210.00 |
| Dec 31, 2025 | 52,210.00 |
| Sep 30, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 12.87 Mn |
| Mar 31, 2024 | 12.87 Mn |
| Dec 31, 2023 | 6.33 Mn |
| Dec 31, 2023 | 6.33 Mn |
| Sep 30, 2023 | 2.65 Mn |
| Sep 30, 2023 | 2.65 Mn |
| Jun 30, 2023 | 3.09 Mn |
| Jun 30, 2023 | 3.09 Mn |
| Mar 31, 2023 | 57,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 378,000.00 |
| Dec 31, 2022 | 378,000.00 |
| Sep 30, 2022 | 1.25 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 3.54 Mn |
| Jun 30, 2022 | 3.54 Mn |
| Mar 31, 2022 | 963,740.00 |
| Mar 31, 2022 | 963,740.00 |
| Dec 31, 2021 | 918,000.00 |
| Dec 31, 2021 | 918,000.00 |
| Sep 30, 2021 | 810,221.00 |
| Sep 30, 2021 | 810,221.00 |
| Jun 30, 2021 | 719,441.00 |
| Jun 30, 2021 | 719,441.00 |
| Mar 31, 2021 | 665,936.00 |
| Mar 31, 2021 | 665,936.00 |
| Dec 31, 2020 | 918,000.00 |
| Dec 31, 2020 | 918,000.00 |
| Sep 30, 2020 | 5.03 Mn |
| Sep 30, 2020 | 5.03 Mn |
| Jun 30, 2020 | 489,383.00 |
| Jun 30, 2020 | 489,383.00 |
| Mar 31, 2020 | 438,822.00 |
| Mar 31, 2020 | 438,822.00 |
| Dec 31, 2019 | 3.36 Mn |
| Dec 31, 2019 | 3.36 Mn |